Sorbonne University
Anakinra safe but did not increase days free from acute myocarditis complications
Anakinra, an interleukin-1R antagonist, was shown to be a safe treatment in patients with acute myocarditis, but did not change the number of days free from complications compared with placebo, a speaker reported.
Oncologists play key role in diagnosing immune checkpoint inhibitor-induced myocarditis
Incidence of immune checkpoint inhibitor-induced myocarditis may increase as more patients receive immunotherapy. In this special report, Healio | HemOnc Today highlights how a multidisciplinary approach can reduce mortality through early recognition and prompt intervention.
Proton pump inhibitors associated with signals for drug-induced lupus
Proton pump inhibitors may be associated with pharmacovigilance signals for the occurrence of drug-induced lupus erythematosus, according to a research letter published in JAMA Dermatology.
Neoadjuvant nivolumab plus ipilimumab active in subset of patients with gastric cancers
Neoadjuvant treatment with nivolumab and ipilimumab led to a high rate of pathologic complete response among patients with resectable microsatellite instability-high/mismatch repair deficient gastric cancers, study results showed.